Product Description
Experience the praiseworthy advancement in oncology care with Nublast - Temozolamide 100 mg Capsules. Specially formulated for the treatment of anaplastic astrocytoma and glioblastoma multiforme, Nublast promises unmatchable efficacy when administered orally under medical supervision. Each blister pack contains 5 capsules of crowning excellence, meeting WHO-GMP standards and designed solely for hospital and clinical use. Get the benefits of this prescription-only medication, marketed by Miracalus Pharma Pvt. Ltd., and avail exclusive promotion opportunities for bulk orders. Intended for professional use only, Nublast sets a new standard in therapeutic reliability.
Application Excellence and Competitive Edge
Nublast - Temozolamide 100 mg Capsules are administered orally, targeting hospital and clinical oncology settings. The application surface is internal, with the site of administration being systemic, focused on specific brain tumors. Its unmatchable formulation and WHO-GMP certification provide a distinctive advantage in efficacy and patient safety. These competitive features make Nublast a crowning choice among oncology therapies, offering medical professionals a reliable and praiseworthy addition to cancer treatment protocols.
Packaging, Payment, and Certification Insights
Nublast capsules are delivered in a market value-driven, five-capsule blister pack, ensuring easy packing and dispatch for hospitals and clinics. Each unit is clearly labeled and protects the medicine from light and moisture. The product comes certified with WHO-GMP approval, attesting to its quality assurance. Flexible payment terms and a competitive list price support bulk procurement for exporters, suppliers, and traders, maximizing accessibility throughout India and supporting optimal storage for a shelf life of 24 months.
FAQ's of Nublast - Temozolamide 100 Mg Capsules:
Q: How should Nublast - Temozolamide 100 mg Capsules be administered?
A: Nublast capsules are designed for oral administration and must be taken exactly as prescribed by a healthcare professional, usually in hospital or clinical settings under strict medical supervision.
Q: What specific conditions does Nublast treat?
A: This medication is indicated for the treatment of certain types of brain tumors, specifically anaplastic astrocytoma and glioblastoma multiforme, helping to manage tumor growth and associated symptoms.
Q: When is Nublast recommended for use?
A: Nublast is generally recommended for oncology patients diagnosed with brain tumors such as anaplastic astrocytoma and glioblastoma multiforme, as part of a coordinated treatment plan established by a medical specialist.
Q: Where can Nublast - Temozolamide 100 mg Capsules be obtained?
A: Nublast is available for hospital and clinical use only, distributed by authorized exporters, suppliers, and traders across India, and requires a valid medical prescription.
Q: What are the packaging and storage requirements for Nublast?
A: Each strip contains five capsules, packed in a protective blister to safeguard from moisture and light. The capsules should be stored below 25C in a dry place to maintain efficacy throughout the 24-month shelf life.
Q: What certifications does Nublast hold?
A: Nublast - Temozolamide 100 mg Capsules are WHO-GMP certified, confirming adherence to international standards of manufacturing quality and safety for oncology medications.